دورية أكاديمية

Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network.

التفاصيل البيبلوغرافية
العنوان: Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network.
المؤلفون: Zambrano LD; From the Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Newhams MM; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts., Simeone RM; From the Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Fleming-Dutra KE; From the Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Halasa N; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Wu M; From the Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Orzel-Lockwood AO; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts., Kamidani S; The Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta and the Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia., Pannaraj PS; Division of Infectious Diseases, Departments of Pediatrics and Molecular Microbiology and Immunology, University of Southern California, Children's Hospital Los Angeles, Los Angeles, California., Chiotos K; Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Cameron MA; Division of Pediatric Hospital Medicine, UC San Diego-Rady Children's Hospital, San Diego, California., Maddux AB; Department of Pediatrics, Section of Critical Care Medicine, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado., Schuster JE; Division of Pediatric Infectious Diseases, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri., Crandall H; Division of Pediatric Critical Care, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah., Kong M; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama., Nofziger RA; Division of Critical Care Medicine, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio., Staat MA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Bhumbra SS; Department of Pediatrics, The Ryan White Center for Pediatric Infectious Disease and Global Health, Indiana University School of Medicine, Indianapolis, Indiana., Irby K; Section of Pediatric Critical Care, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, Arkansas., Boom JA; Department of Pediatrics, Baylor College of Medicine, Immunization Project, Texas Children's Hospital, Houston, Texas., Sahni LC; Department of Pediatrics, Baylor College of Medicine, Immunization Project, Texas Children's Hospital, Houston, Texas., Hume JR; Division of Pediatric Critical Care, University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota., Gertz SJ; Division of Pediatric Critical Care, Department of Pediatrics, Cooperman Barnabas Medical Center, Livingston, New Jersey., Maamari M; Department of Pediatrics, Division of Critical Care Medicine, University of Texas Southwestern, Children's Medical Center Dallas, Texas., Bowens C; Department of Pediatrics, Division of Critical Care Medicine, University of Texas Southwestern, Children's Medical Center Dallas, Texas., Levy ER; Divisions of Pediatric Infectious Diseases and Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota., Bradford TT; Division of Cardiology, Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital of New Orleans, New Orleans, Louisiana., Walker TC; Department of Pediatrics, University of North Carolina at Chapel Hill Children's Hospital, Chapel Hill, North Carolina., Schwartz SP; Department of Pediatrics, University of North Carolina at Chapel Hill Children's Hospital, Chapel Hill, North Carolina., Mack EH; Division of Pediatric Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina., Guzman-Cottrill JA; Division of Infectious Diseases, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon., Hobbs CV; Division of Infectious Diseases, Department of Pediatrics, and Department of Cell and Molecular Biology, Children's of Mississippi, University of Mississippi Medical Center, Jackson, Mississippi., Zinter MS; Divisions of Critical Care Medicine and Allergy, Immunology, and Bone Marrow Transplant, Department of Pediatrics, University of California San Francisco, San Francisco, California., Cvijanovich NZ; Division of Critical Care Medicine, UCSF Benioff Children's Hospital Oakland, California., Bline KE; Division of Pediatric Critical Care Medicine, Nationwide Children's Hospital Columbus, Ohio., Hymes SR; Division of Pediatric Infectious Diseases, Department of Pediatrics, Bernard and Millie Duker Children's Hospital, Albany Med Health System, Albany, New York., Campbell AP; From the Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Randolph AG; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.; Departments of Anaesthesia and Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
مؤلفون مشاركون: Overcoming COVID-19 Investigators
المصدر: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 Mar 01; Vol. 43 (3), pp. 242-249. Date of Electronic Publication: 2023 Dec 25.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0987 (Electronic) Linking ISSN: 08913668 NLM ISO Abbreviation: Pediatr Infect Dis J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Baltimore, Md. : Williams & Wilkins, c1987-
مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control, Child ; Humans ; Child, Preschool ; SARS-CoV-2 ; COVID-19 Vaccines ; Hospitalization ; Vaccination
مستخلص: Background and Objectives: In June 2022, the mRNA COVID-19 vaccination was recommended for young children. We examined clinical characteristics and factors associated with vaccination status among vaccine-eligible young children hospitalized for acute COVID-19.
Methods: We enrolled inpatients 8 months to <5 years of age with acute community-acquired COVID-19 across 28 US pediatric hospitals from September 20, 2022 to May 31, 2023. We assessed demographic and clinical factors, including the highest level of respiratory support, and vaccination status defined as unvaccinated, incomplete, or complete primary series [at least 2 (Moderna) or 3 (Pfizer-BioNTech) mRNA vaccine doses ≥14 days before hospitalization].
Results: Among 597 children, 174 (29.1%) patients were admitted to the intensive care unit and 75 (12.6%) had a life-threatening illness, including 51 (8.5%) requiring invasive mechanical ventilation. Children with underlying respiratory and neurologic/neuromuscular conditions more frequently received higher respiratory support. Only 4.5% of children hospitalized for COVID-19 (n = 27) had completed their primary COVID-19 vaccination series and 7.0% (n = 42) of children initiated but did not complete their primary series. Among 528 unvaccinated children, nearly half (n = 251) were previously healthy, 3 of them required extracorporeal membrane oxygenation for acute COVID-19 and 1 died.
Conclusions: Most young children hospitalized for acute COVID-19, including most children admitted to the intensive care unit and with life-threatening illness, had not initiated COVID-19 vaccination despite being eligible. Nearly half of these children had no underlying conditions. Of the small percentage of children who initiated a COVID-19 primary series, most had not completed it before hospitalization.
Competing Interests: The authors have no conflicts of interest to disclose.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: N Engl J Med. 2022 May 19;386(20):1899-1909. (PMID: 35353976)
Lancet. 2007 Oct 20;370(9596):1453-7. (PMID: 18064739)
N Engl J Med. 2022 Feb 24;386(8):713-723. (PMID: 35021004)
MMWR Morb Mortal Wkly Rep. 2023 Feb 17;72(7):177-182. (PMID: 36795625)
N Engl J Med. 2022 Nov 3;387(18):1673-1687. (PMID: 36260859)
N Engl J Med. 2023 Feb 16;388(7):621-634. (PMID: 36791162)
Clin Infect Dis. 2023 Feb 8;76(3):e1031-e1039. (PMID: 35867698)
MMWR Morb Mortal Wkly Rep. 2022 Sep 02;71(35):1115-1120. (PMID: 36048728)
Pediatrics. 2021 Dec 22;149(1):. (PMID: 34935038)
Vaccine. 2022 Mar 1;40(10):1404-1412. (PMID: 35131135)
Pediatrics. 2023 Jul 1;152(1):. (PMID: 37278199)
JAMA Pediatr. 2023 Dec 1;177(12):1324-1331. (PMID: 37843856)
JAMA Pediatr. 2023 Oct 1;177(10):1073-1084. (PMID: 37603343)
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429-436. (PMID: 35298458)
Pediatrics. 2023 Aug 1;152(2):. (PMID: 37489285)
MMWR Morb Mortal Wkly Rep. 2022 Jul 01;71(26):859-868. (PMID: 35771731)
MMWR Morb Mortal Wkly Rep. 2023 Feb 17;72(7):183-189. (PMID: 36795658)
Pediatr Crit Care Med. 2022 Dec 1;23(12):1056-1066. (PMID: 36454002)
Clin Infect Dis. 2021 Aug 16;73(4):e947-e954. (PMID: 33502489)
Nat Commun. 2022 May 27;13(1):2979. (PMID: 35624101)
Clin Infect Dis. 2022 Aug 25;75(2):230-238. (PMID: 35024795)
معلومات مُعتمدة: CC999999 United States ImCDC Intramural CDC HHS
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20231225 Date Completed: 20240223 Latest Revision: 20240723
رمز التحديث: 20240723
مُعرف محوري في PubMed: PMC11261536
DOI: 10.1097/INF.0000000000004225
PMID: 38145397
قاعدة البيانات: MEDLINE
الوصف
تدمد:1532-0987
DOI:10.1097/INF.0000000000004225